| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/07/1998 | CN1169425A Fluorinated vitamin D3 analogs |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/07/1998 | CN1036918C Novel benzopyran derivatives and activating agent containing same |
| 01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
| 01/06/1998 | US5705654 Antiandrogens |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705528 Farnesyl derivatives and pharmaceutical compositions containing them |
| 01/06/1998 | US5705526 Hypercholesterolemia therapeutic agent |
| 01/06/1998 | US5705523 Thromboxane a2 synthetase inhibitors |
| 01/06/1998 | US5705515 Having reduced side effects |
| 01/06/1998 | US5705511 Fused pyrrolocarbazoles |
| 01/06/1998 | US5705507 Aplha-substituted-3-benzyl-benzofurans |
| 01/06/1998 | US5705504 Platelet activating factor |
| 01/06/1998 | US5705498 Piperidine derivatives as 5-HT4 receptor antagonists |
| 01/06/1998 | US5705497 Inotropic, antiarrhythmia agents |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705489 Having antithrombotic activity |
| 01/06/1998 | US5705484 Biologically active polypeptide fusion dimers |
| 01/06/1998 | US5705483 Glucagon-like insulinotropic peptides, compositions and methods |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | US5705167 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders |
| 01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/06/1998 | US5705144 Skin lightening composition and radiation resistance |
| 01/02/1998 | CA2206752A1 Benzothiophene compounds, intermediates, processes, and methods of use |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049805A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/31/1997 | WO1997049736A2 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997049710A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/31/1997 | WO1997049707A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049704A1 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049700A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 12/31/1997 | WO1997049689A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 12/31/1997 | WO1997049682A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049673A1 Selective thrombin inhibitors |
| 12/31/1997 | WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 12/31/1997 | WO1997049420A1 Lectin compositions and uses thereof |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | WO1997049414A1 Manufacturing process for the production of purified transferrin |
| 12/31/1997 | WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 12/31/1997 | WO1997049405A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | WO1997049387A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | WO1997045528A3 Mammalian tolloid-like gene and protein |
| 12/31/1997 | WO1997035873A3 Peptides with antiproliferative properties |
| 12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/31/1997 | CN1169145A Novel farnesyl tranfering enzyme inhibitor, prepn. method and medicinal composition thereof |
| 12/31/1997 | CN1168886A Process for production of amidinobenzofuran and amidionbenzothiophen derivatives and salt thereof |
| 12/31/1997 | CN1168885A Process for prodn. of amidinoindole derivatives and salts thereof |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2259222A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 12/31/1997 | CA2258885A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | CA2258851A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/31/1997 | CA2258744A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CA2258199A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | CA2257964A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/30/1997 | US5703240 Analgesics; antiinflammatory agents; nervous system disorders; psychological disorders; gastrointestinal disorders |
| 12/30/1997 | US5703237 N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands |
| 12/30/1997 | US5703205 Laminin a chain polypeptides from the amino terminal golbular domain |
| 12/30/1997 | US5703121 Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound |
| 12/30/1997 | US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger |
| 12/30/1997 | US5703109 Cyanophenyl-1,2,4-triazole derivative |
| 12/30/1997 | US5703106 Treating various cardiovascular, urogenital, brain disorders |
| 12/30/1997 | US5703099 Treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 12/30/1997 | US5703098 Inhibitors of cytokines including tumor necrosis factor |
| 12/30/1997 | US5703097 Antiulcer agents |
| 12/30/1997 | US5703095 Prevention ferritin from releasing oxygen |
| 12/30/1997 | US5703087 Phenyl indole compounds |
| 12/30/1997 | US5703084 Adenosine deaminase inhibitors |
| 12/30/1997 | US5703083 Therapy for psychological disorders |
| 12/30/1997 | US5703082 Enantiomers of 1- (4-chlorophenyl)phenylmethyl!- (4-methylphenyl)sulfonyl!pi |
| 12/30/1997 | US5703074 Osteoporosis |
| 12/30/1997 | US5703073 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 12/30/1997 | US5703070 Psychological disorders |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/30/1997 | US5703050 Inhibit platelet aggregation, metastasis of carcinoma cells, osteoclast binding to bone surface |
| 12/30/1997 | US5702698 Promoting production of colony stimulating factor |
| 12/30/1997 | CA2142707C Benzo-fused lactams promote release of growth hormone |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
| 12/29/1997 | EP0814087A2 Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans |
| 12/29/1997 | EP0814080A1 Squalene synthetase inhibitors |
| 12/29/1997 | EP0814077A1 Benzoylguanidines, process for their preparation and medicaments containing them |
| 12/29/1997 | EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices |
| 12/29/1997 | EP0813872A1 Berberine derivates for inhibiting hsp27 production |
| 12/29/1997 | EP0813871A1 Berberine derivates for inhibiting production of HSP47 |
| 12/29/1997 | EP0813870A1 Use of darifenacin to enhance cognitive functions |
| 12/29/1997 | EP0813869A1 Use of strontium salts for the treatment of arthritis |
| 12/29/1997 | EP0813868A2 Retroviral protease inhibitors |
| 12/29/1997 | EP0813867A2 Retroviral protease inhibitors |
| 12/29/1997 | EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 12/29/1997 | EP0813542A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 12/29/1997 | EP0813537A1 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |